Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT04220749 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Radiotherapy vs. Trans-Oral Surgery for HPV-Negative Oropharyngeal Squamous Cell Carcinoma

Name: Radiotherapy vs. Trans-Oral Surgery for HPV-Negative Oropharyngeal Squamous Cell Carcinoma — clinical trial record (NCT04220749)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

StatusRecruiting

PhasePhase 2

SponsorLondon Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's

Started2020-06-25

View on ClinicalTrials.gov ↗

Amendment history

2020-09-02

Not Yet Recruiting→Recruiting Study Status, Oversight, Study Design, Contacts/Locations v1

Trial statusNot Yet Recruiting→Recruiting

Start dateestimated 2020-02→confirmed 2020-06-25

Enrollment target70→68

Study sites0→1

2020-01-06

Original filing

London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's

155 trials monitored

See 11 trials at risk

Head & Neck Cancer

2,051 trials monitored

See 116 trials at risk

The goal of this randomized phase II study is a formal comparison of radiotherapy versus trans-oral surgery as the primary treatment of HPV-negative patients with early-stage oropharyngeal carcinoma.

Trial Details

NCT Number	NCT04220749
Lead Sponsor	London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
Conditions	Head and Neck Cancer, Oropharyngeal Squamous Cell Carcinoma
Enrollment	68 participants
Start Date	2020-06-25
Primary Completion	2028-02 (estimated)
Study Completion	2028-02 (estimated)
Updated on ClinicalTrials.gov	2020-09-04